Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma. [electronic resource]
- Cancer letters May 2015
- 302-9 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1872-7980
10.1016/j.canlet.2015.02.036 doi
Animals Antibodies, Monoclonal--immunology Antibody Specificity CD47 Antigen--biosynthesis Carcinoma, Hepatocellular--immunology Cell Movement--immunology Hep G2 Cells Humans Liver Neoplasms--immunology Macrophages--immunology Male Mice Mice, SCID Phagocytosis--immunology Xenograft Model Antitumor Assays